Initiatives and funding
2025ÌýCancer Theme Research Seed Grants ($50,000)
Collaboration is fundamental to research quality and success. This grant program aims to promote cross-disciplinary collaboration within the Â鶹Éçmadou cancer research community through the award of seed grants. The objective of the grant is to initiate collaborative team science, leading to increased competitiveness for program-level grant funding, staff exchanges for education and training, and shared use of infrastructure.Ìý
Ìý
Recipients |
Theme |
Affiliation |
Grant Title |
| Amy Logan | Cancer | Childrens Cancer Institute | Tumour-targeted siRNA conjugates for therapeutic gene silencing in brain cancer. |
| Marjan Naeini | Cancer | Garvan Institute | Investigating Genomic and Epigenomic Drivers of Chemotherapy Resistance in Oesophageal Adenocarcinoma: A Pilot Study Using Nanopore Sequencing. |
| Venessa Chin | Cancer | Garvan Institute | Unravelling Genomic Diversity in ALK-Positive Non-Small Cell Lung Cancer: Insights from Paired RNA/DNA Sequencing of Circulating Tumour Cells. |
Ìý Shannon Chiang Ìý |
Cancer | School of Biomedical Sciences | Pre-clinical development of a novel RNA-based therapy for pancreatic cancer. |
Ìý S M Zahid Hosen Ìý |
Cancer | Ingham Institute | Mapping Metabolic Dysregulation in Pancreatic Stellate: Implications for Tumour Growth and Immune Evasion in Pancreatic Cancer |
2025 -2028 White Walker Cancer Research Scholarship Applications - T1 2025 Start - CLOSED
The Â鶹Éçmadou Faculty of Medicine and Health - White Walker Cancer Research Scholarship is a full 4-year PhD scholarship offered to outstanding domestic candidates to be trained to conduct research specifically in the field of Cancer, under the supervision of experienced academics affiliated with the Faculty of Medicine and Health at Â鶹Éçmadou.
The scholarship comprises a full stipend of $45,000 per annum for a maximum of 4 years; a career development fund of $10,000 per annum; a comprehensive Research Training and Career Development program; and a 3-month (1 term) integrated internship with an academic unit or industry partner.
2024 Cancer Theme Research Seed Grants ($50,000)
Seed grants are offered to support new and strategic research, with a focus on collaboration across organisations and disciplines. Unsuccessful seed grants are eligible for other forms of support, including grant preparation support or leverage funds for external funding applications above $2m and philanthropic exposure.
Recipients |
Affiliation |
Grant Title |
Dr. Angelica Merlot |
Children’s Cancer Institute |
Targeting Cell Surface Proteins in Deadly Paediatric and Adult Brain Cancers |
Dr. Daryan Kempe |
School of Biomedical Sciences/ Molecular Medicine, Â鶹Éçmadou |
Dissecting crosstalk between neutrophils and T cells in microbial therapy of pancreatic cancer |
Dr. Frank Lin |
The Garvan Institute |
Establishing clinical correlates of SLC7A11 expression in pancreatic adenocarcinoma through histomorphology and deep learning analyses: the first step towards clinical translation |
Children’s Cancer Institute |
Targeting the YTHDF2 oncogene with non-toxic copper chelation in neuronal cancers |
|
The Garvan Institute |
Development of Novel Treatment Response Criteria in Prostate-specific Membrane Antigen (PSMA) SPECT/CT for Optimizing 177Lu-PSMA radionuclide therapy in Patients with Advanced Prostate Cancer (ReSPECT) |
White Walker Cancer Research Scholarship
The Â鶹Éçmadou Faculty of Medicine and Health - White Walker Cancer Research Scholarship is a full 4-year PhD scholarship offered to outstanding domestic candidates to be trained to conduct research specifically in the field of Cancer, under the supervision of experienced academics affiliated with the Faculty of Medicine and Health at Â鶹Éçmadou.
Recipient |
|
2024-2028 |
Lucy Haggstrom |
2022-2026 |
Michael Trpceski |
-
2023 Cancer Symposium Poster Presentation Winners
Recipient
Affiliation
Prize
Carley Purcell
The Garvan Institute
PhD Student Poster Prize
Allegra Freelander
The Garvan Institute
Early Career Researcher Poster Prize
Leila Eshraghi
The Garvan Institute
Mid-career Researcher Poster Prize
Vikneswary Batumalai
School of Clinical Medicine
Consumer Poster Prize
Ìý
2022 Cancer Symposium Poster Presentation Winners
Recipient
Prize
Felix Kohane
PhD Student Poster Prize
Beata Kiedik
PhD Student Poster Prize
Dr. Shabani Gupta
Early Career Researcher Poster Prize
Dr. Beatriz Perez San Juan
Mid-career Researcher Poster Prize
Ìý
2023 Cancer Theme Research Seed Grants ($50,000)
Recipients
Affiliation
Grant Title
Dr. Joanna Achinger-Kawecka
The Garvan Institute
Targeting enhancers to overcome breast cancer resistance to CDK4/6 inhibition
Dr. Craig Haifer
School of Clinical Medicine
St Vincent's Healthcare Clinical Campus
Orally Administered Faecal Microbial Transplantation in the Management of Immune Checkpoint Inhibitor Associated Colitis - A randomised control trial to assess safety and preliminary efficacy
Dr. Dongli Liu
School of Clinical Medicine (WCH)
Establishing 3D Ovarian Cancer Organoids Using Novel Biomaterials
Dr. Kendelle Murphy
The Garvan Institute
Uncoupling the tumour-stroma feedback loop in pancreatic cancer using the ROCK2 inhibitor KD025, in combination with contemporary Folfirinox chemotherapy.
Dr. Mei Ling Yap
The George Institute for Global Health
SoCM SWS Clinical Campus
Leveraging big data to attain equity in cancer control for refugees and recent migrants
Ìý
2022 Cancer Theme Research Seed Grants ($50,000)
Recipients
Affiliation
Grant Title
Dr. Benjamin Daniels
Centre for Big Data Research
Understanding the impact of SARS-CoV-2 (COVID-19) on Australian cancer treatment
Dr. Leila Eshraghi
The Garvan Institute
Elucidating the oncogenic role of telomere dysfunction in drug resistant ER+ breast cancer
Dr. Jackie Huang
Children’s Cancer Institute
Sensitisation and eradication of chemo-resistant T-ALL by repurposing epigenetic and myeloid-directed drugs
Dr. Ernesto Moles
Children’s Cancer Institute
In vivo controlled reprogramming of T cells with chimeric antigen receptor-encoding mRNA nanoparticles to potently suppress brain cancer
Dr. Brooke Pereira
The Garvan Institute
Repurposing PCSK9 inhibitor PF-846 to enhance immunotherapy in pancreatic cancer